2020•Clinical Genitourinary CancerOpen access

Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy

Lucía Carril-Ajuria, David Lora, Alberto Carretero-González, Maricruz Martín-Soberón, Patricia Rioja, Daniel Castellano, Guillermo de Velasco

Open full text 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Nivolumab, Ipilimumab, Medicine, Internal medicine, Oncology, Renal cell carcinoma, Adverse effect, Salvage therapy

Back to paper search Browse research topics Original source

Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy — Research Paper | ScholarLens